Mechanism of injury-provoked poliomyelitis

Journal of Virology

Volumn 72, Issue 6, 1998, Pages 5056-5060

  Gromeier, Matthias ^a   Wimmer, Eckard ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLIOMYELITIS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; DISEASE PREDISPOSITION; MOUSE; MUSCLE INJURY; NERVE FIBER TRANSPORT; NONHUMAN; PARALYSIS; POLIOMYELITIS; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; SKELETAL MUSCLE; SPINAL CORD LESION; VIRUS INFECTION; VIRUS LOAD; VIRUS REPLICATION;

EID: 0031954777     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.6.5056-5060.1998     Document Type: Article

References (28)

1. Anderson, G., and A. Skaar. 1962. Poliomyelitis occurring after antigen injections. Pediatrics 7:741-759.
2. Asaad, F., and W. F. Cockburn. 1982. The relation between acute persisting spinal paralysis and poliomyelitis vaccine - results of a ten-year enquiry. Bull. W. H. O. 60:231-233.
3. Bodian, D. 1955. Viremia, invasiveness, and the influence of injections. Ann. N.Y. Acad. Sci. 61:877-882.
4. Bodian, D. 1954. Viremia in experimental poliomyelitis. II. Viremia and the mechanism of the "provoking effect" of injections or trauma. Am. J. Hyg. 60:358-370.
5. Curtis, R., K. M. Adryan, Y. Zhu, P. J. Harkness, R. M. Lindsay, and P. S. DiStefano. 1993. Retrograde axonal transport of ciliary neurotrophic factor is increased by peripheral nerve injury. Nature 365:253-255.
6. Esteves, K. 1988. Safety of oral poliomyelitis vaccine: results of a WHO enquiry. Bull. W. H. O. 66:739-746.
7. Georgescu, M.-M., F. Delpeyroux, M. Tardy-Panit, J. Balanant, M. Combiescu, A. A. Combiescu, S. Guillot, and R. Crainic. 1994. High diversity of poliovirus strains isolated from the central nervous system from patients with vaccine-associated paralytic poliomyelitis. J. Virol. 68:8089-8101.
8. Gromeier, M., L. Alexander, and E. Wimmer. 1996. Internal ribosomal entry site substitution eliminates neurovirulence in intergeneric poliovirus recombinants. Proc. Natl. Acad. Sci. USA 93:2370-2375.
9. Gromeier, M., H. H. Lu, and E. Wimmer. 1995. Mouse neuropathogenic poliovirus strains cause damage in the central nervous system distinct from poliomyelitis. Microb. Pathog. 18:253-268.
10. Guyer, B., A. A. E. Bisong, J. Gould, M. Brigaud, and M. Aymard. 1980. Injections and paralytic poliomyelitis in tropical Africa. Bull. W. H. O. 58:285-291.
11. Hill, A. B., and J. Knowelden. 1955. Inoculation and poliomyelitis: a statistical investigation in England and Wales in 1949. Br. Med. J. II:1-6.
12. Koike, S., C. Taya, T. Kurata, S. Abe, I. Ise, Y. Yonekawa, and A. Nomoto. 1991. Transgenic mice susceptible to poliovirus. Proc. Natl. Acad. Sci. USA 88:951-955.
13. Lancet. 1992. Provocation poliomyelitis. Lancet 340:1005-1006. (Editorial.)
14. McCloskey, B. P. 1950. The relation of prophylactic inoculations to the onset of poliomyelitis. Lancet i:659-663.
15. Melnick, J. L. 1995. Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses, p. 549-605. In B. N. Fields et al. (ed.), Virology. Raven Press, N.Y.
16. Minor, P. D. 1992. The molecular biology of polio vaccines. J. Gen. Virol. 73:3065-3077.
17. Modlin, J. F. 1995. Poliomyelitis and poliovirus immunization, p. 195-220. In H. A. Rotbart (ed.), Human enterovirus infections. American Society for Microbiology, Washington, D.C.
18. Nathanson, N., and D. Bodian. 1961. Experimental poliomyelitis following intramuscular virus injection. I. The effect of neural block on a neurotropic and a pantropic strain. II. Viremia and the effect of antibody. Bull. Johns Hopkins Hosp. 108:308-333.
19. Nathanson, N., and A. D. Langmuir. 1963. The Cutter incident. Am. J. Hyg. 78:16-81.
20. Ren, R., R. Costantini, E. J. Gorgacz, J. J. Lee, and V. R. Racaniello. 1990. Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis. Cell 63:353-362.
21. Ren, R., and V. R. Racaniello. 1992. Poliovirus spreads from muscle to the central nervous system by neural pathways. J. Infect. Dis. 166:747-752.
22. Strebel, P. M., N. lon-Nedelcu, A. L. Baughman, R. M. Sutter, and S. L. Cochi. 1995. Intramuscular injections within 30 days of immunization with oral poliovirus vaccine - a risk factor for vaccine-associated paralytic poliomyelitis. N. Engl. J. Med. 332:500-506.
23. Sutter, R. W., P. A. Patriarca, A. J. M. Suleiman, S. Brogan, P. G. Malankar, S. L. Cochi, A. A. Al-Ghassani, and M. S. el-Bualy. 1992. Attributable risk of DTP (diphtheria and tetanus toxoids and pertussis vaccine) injection in provoking paralytic poliomyelitis during a large outbreak in Oman. J. Infect. Dis. 165:444-449.
24. Trueta, J., and R. Hodes. 1954. Provoking and localizing factors in poliomyelitis. An experimental study. Lancet i:998.
25. Wimmer, E., C. U. T. Hellen, and X. M. Cao. 1993. Genetics of poliovirus. Annu. Rev. Genet. 27:353-436.
26. World Health Organization. 1989. Expanded programme on immunization, global poliomyelitis eradication by the year 2000: manual for managers of immunization programmes on activities related to polio eradication, p. 35-64. World Health Organization, Geneva, Switzerland.
27. Wyatt, H. V. 1985. Provocation of poliomyelitis by multiple injections. Trans. R. Soc. Trop. Med. Hyg. 79:355-358.
28. Yang, W. X., T. Terasaki, K. Shiroki, S. Ohka, J. Aoki, S. Tanabe, T. Nomura, E. Terada, Y. Sugiyama, and A. Nomoto. 1997. Efficient delivery of circulating poliovirus to the central nervous system independently of poliovirus receptor. Virology 229:421-428.